Source: Annual Congress 2005 - Cellular and molecular mechanisms in COPD
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Beghé, S. Baraldo, F. Calabrese, E. Bazzan, F. Rea, M. Loy, R. Zuin, P. Maestrelli, G. Turato, L. Fabbri, M. Saetta (Padova, Modena, Italy). TGF-β1 type II receptor (TGF-βRII) expression in pulmonary arteries of patients with severe COPD. Eur Respir J 2005; 26: Suppl. 49, 695

Member's Comments

No comment yet.

Related content which might interest you: Expression of TGFβ-1 and TGFβ-1RII in pulmonary arteries of patients with severe COPD Source: Eur Respir J 2003; 22: Suppl. 45, 392s Year: 2003 Altered kinetics of TGFβ receptor II expression in pulmonary fibroblasts of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 224s Year: 2005 The influence of diabetes type 2 (D2) on pulmonary hypertension (PH) in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 60s Year: 2005 Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD Source: Eur Respir J 2006; 28: 556-562 Year: 2006 Endothelin receptor antagonist (ETRA) bosentan (B) in patients with severe pulmonary hypertension (PH) associated with pulmonary disease Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Expression of epidermal growth factor receptor (EGFR) in the bronchial epithelium of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011 Polymorphisms in the type IV collagen alpha3 gene and the risk of COPD Source: Eur Respir J 2008; 32: 35-41 Year: 2008 Longterm treatment effects of pulmonary hypertantion (PH) in idiopathic pulmonary fibrosis (IPF) patients by endothelin receptor blockade (Bosentan) Source: Eur Respir J 2007; 30: Suppl. 51, 120s Year: 2007 Decreased expression of TGFβ1 type II receptor in bronchial glands of smokers with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 98s Year: 2004 Responses to sitaxsentan in patients with functional class II compared to III/IV pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Pulmonary gene expression of tenascin-C and fibronectin in chronic obtructive pulmonary disease (COPD) Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Relationship between pulmonary hypertension (PH) and lung function in severe COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 252s Year: 2001 The use of symbicort in the treatment of patients with I and II stages of pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 85s Year: 2007 Overexpression of angiotensin II type 1 receptor (AGTR1) and lymphatic vasculature rarefaction is present in scleroderma with pulmonary compromised Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients? Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Microarray analysis of pulmonary gene expression in mice lacking the vasoactive intestinal peptide (VIP) gene: confirmation of a role in asthma and pulmonary arterial hypertension (PAH) Source: Annual Congress 2006 - Cellular mechanisms of airway disease Year: 2006 Increased expression of phosphodiesterase 4 (PDE4) A, B and D in alveolar macrophages from chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2011 - Macrophages and neutrophils in chronic lung disease Year: 2011 Association between AGTTGFB1ESR1, and VDR gene variants with idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis (PS) clinical features Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases Year: 2017 Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 564s Year: 2002 Comparison of CT scan-measured pulmonary artery to aorta ratio of combined pulmonary fibrosis and emphysema (CPFE) and COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016